The study, for which the EASP has obtained data from the Ministry of Health for the period between 2016 and 2021, will analyze the penetration of biosimilar medicines in our country. The EASP will direct the study, which will have the collaboration of BioSim, and various professionals from the economic, health and management fields will participate.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
